Actelion Pharmaceuticals

Actelion Pharmaceuticals

Actelion Pharmaceuticals

Overview
Date Founded

1997

Headquarters

Gewerbestrasse 16, Allschwil, CH-4123, CHE

Type of Company

Private

Employees (Worldwide)

5,001 - 10K

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology
Wholesale: Consumer Non-Durables/Sundries
Medical Support Services

Company Description

Actelion Pharmaceuticals Ltd., part of Johnson & Johnson, is a company headquartered in Allschwil, Switzerland. The firm develops and distributes molecular weight drugs.

Executives & Employees

Chief Executive Officer, Founder

Co-Founder

Founder

Founder

Executive Vice President & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Senior Vice President, Group General Counsel & Corporate Secretary

Executive Vice President & Chief Business Development Officer

Investor

Board of Directors

Operating Partner at Advent International LLC

Chief Executive Officer & Director at Idorsia Ltd.

Director at PTS Intermediate Holdings LLC

Chairman at Max Planck Florida Corporation

Former President, Pharmaceuticals at GlaxoSmithKline Plc

Former Chief Executive Officer at PostNL NV

Head of Audit Committee at Sonova Holding AG

Managing Director Portfolio Manager-International Equities, Global Equities at Avalon Advisors LLC

General Partner at Anttila & Co. Advisors

Founder at Biotechnology Innovation Organization

Paths to Actelion Pharmaceuticals
Potential Connections via
Relationship Science
You
Actelion Pharmaceuticals
Investors
Details Hidden

Healthcap is an active, long-term manager which invests in pharmaceutical, biotechnology and medical technology companies globally. As a multi-stage fund, the firm provides and participates in financing through all stages of company evolution. Their funds have no geographic restrictions.Healthcap's main investment style is to be lead investor and the firm acts predominantly as an influential minority investor, seeking to invest in the commercialization of innovations in medical science where they believe that the structural changes taking place in the pharmaceutical industry create significant opportunities for knowledgeable investors to achieve high financial returns.The firm partners with investee companies and founders, seeking board representation to assist with strategy formulation in the areas of science, business development and finance. They encourage substantial ownership by entrepreneurs and scientific founders and insist on implementing employee equity ownership programs to attract and reward key personnel.Healthcap's in-house science team evaluates the scientific merits of investment proposals and their in-house transaction team structures the transactions. The firm invests independently or in partnership with other investor groups.

Details Hidden

General Partner at Sofinnova Ventures, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Actelion Pharmaceuticals. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Actelion Pharmaceuticals's profile does not indicate a business or promotional relationship of any kind between RelSci and Actelion Pharmaceuticals.